compound · derived
Durvalumab
5 trials · 0 approvals
| Trials | 5 |
|---|---|
| Approvals | 0 |
| Phases | Phase 1, Phase 1, Phase 2, Phase 2, Phase 3 |
Provenance
- Source: Derived from ClinicalTrials.gov and openFDA
- Fetched at: 2026-10-28T02:30:44.792Z
- Licence class: internal-only
- Verdict: derived
- Entity id: durvalumab
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.